In a groundbreaking study, researchers at Fudan University in China claim to have cured mice with breast cancer in just two weeks after implanting a microdevice that deprives cancer cells of oxygen. The innovation was announced at the Science Advances magazine on March 31st.

The self-charging battery works with salt water injected into the cancerous area, consuming the cells’ oxygen in a process called hypoxia. The researchers explain that this system causes cancer cells to “starve” without the necessary oxygen to develop.

It also allows a new class of drugs, hypoxia-activated prodrugs (HAPs), to kill tumors while leaving healthy tissue intact.

The device was implanted in the armpits of 25 laboratory mice with breast cancer. “After 14 days, tumors in the five mice that received the battery and drug treatment shrank by an average of 90% – with four of the mice experiencing tumor disappearance,” says lead study author Fan Zhang, a professor at Fudan University. .

Tumors in the other groups of rodents — which included those that received no treatment, those that received only PAH drugs, a non-functional implanted battery, or just the working battery — either remained the same size or had enlarged by the end of the study.

Advertising by Metrópoles 1 partner
Advertising by Metrópoles 2 partner
Advertising by Metrópoles 3 partner
Advertising by Metrópoles 4 partner
Advertising by Metrópoles 5 partner
Advertising by Metrópoles 6 partner
Advertising by Metrópoles 7 partner

0

Professor Zhang explains that tumors often deplete oxygen in nearby non-cancerous tissues as they grow, resulting in oxygen starved or hypoxic cells. The battery operated for up to 500 hours inside the mice’s tissue producing very low voltage electricity.

“Hypoxia-activated prodrugs aim to take advantage of this feature by targeting only hypoxic cells – minimizing damage to healthy cells and reducing side effects,” explains Zhang.

In an interview with New Scientist magazine, Professor Randall Johnson, from the University of Cambridge, who was not involved in the study, considers that inducing hypoxia in a tumor may increase the risk of the cancer spreading. “Although this does not seem to have occurred in these mice, the costs and benefits of using the battery in people need to be evaluated before any human treatment,” says Johnson to the publication.

Get news from metropolises on your Telegram and stay on top of everything! Just access the channel: https://t.me/metropolesurgente.

California18

Welcome to California18, your number one source for Breaking News from the World. We’re dedicated to giving you the very best of News.

Leave a Reply